Swiss warn on H1N1 vaccine with autoimmune disease
January 20, 2010
* Says autoimmune patients should not take Novartis vaccine
* Regulator says could lead to intensifying of disease
ZURICH (Reuters) - Switzerland's medical regulator recommended patients with serious autoimmune diseases should not use an H1N1 flu vaccine from Novartis, saying there were no studies assessing the inoculation in that segment of the population.
Swissmedic said on Wednesday it could not be ruled out that either or both of the adjuvant -- which can enhance the immune response -- and the antigen, or less active ingredient, could lead to an intensifying of autoimmune diseases.
Autoimmune diseases, like rheumatoid arthritis, are caused by an overly active immune system attacking its own body, targeting substances which are normally present.
Novartis was not immediately available to comment.
Copyright © 2010 Reuters Limited. All rights reserved.
Republication or redistribution of Reuters content, including by framing or
similar means, is expressly prohibited without the prior written consent of
Reuters. Reuters shall not be liable for any errors or delays in the
content, or for any actions taken in reliance thereon.
Reuters and the Reuters sphere logo are registered trademarks and
trademarks of the Reuters group of companies around the world.